Physician profile
Kristen M Witkowski
NPI 1184874976
$1,392.55
in general payments reported to CMS, 2019-2025
22 companies · $278 in 2025
The $278 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $65.07 · 2021: $127 · 2022: $27.78 · 2023: $147 · 2024: $211 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $353.49 | 2019-2023 | Liletta |
| Hologic Sales and Service, LLC | $216.11 | 2021-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Baxter Healthcare | $122.49 | 2019 | |
| Pfizer INC. | $95.63 | 2023-2024 | |
| Astellas Pharma US INC | $88.37 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $57.04 | 2025 | |
| Myovant Sciences INC. | $55.20 | 2021-2022 | |
| Covidien LP | $52.73 | 2019 | |
| Boston Scientific Corporation | $45.54 | 2019 | |
| Therapeuticsmd, INC. | $37.89 | 2019-2020 | |
| Exeltis, USA INC. | $37.70 | 2025 | Slynd |
| Dexcom, INC. | $30.97 | 2025 | Dexcom G6 Transmitter |
| Sage Therapeutics, LLC | $25.22 | 2025 | Zurzuvae |
| Millicent US INC | $25.06 | 2024 | Intrarosa |
| Sumitomo Pharma America, INC. | $25.01 | 2023 | Myfembree |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $23.37 | 2025 | |
| Coopersurgical, INC. | $21.12 | 2023 | Mara Console |
| Meditrina | $21.01 | 2024 | |
| Mimedx Group, INC. | $18.13 | 2024 | |
| Smith+Nephew, INC. | $14.91 | 2024 | Pico 14 |
| Organon LLC | $12.89 | 2025 | Nexplanon |
| Amag Pharmaceuticals, INC. | $12.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Witkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.